09 Mar Uncategorized EastGate Biotech Attends Arab Health Conference Seeking Additional Joint Venture Partnerships March 9, 2022 By admin 0 comments e both our JV partner and Bill represent Eastgate at the conference,” said Anna Gluskin CEO of Eastgate Biotech. “Not only can they sp...Continue reading
09 Mar Uncategorized EastGate Biotech Appoints Additional Consultants in Preparation of Progressing Company Developments in 2019 March 9, 2022 By admin 0 comments WEST CALDWELL, NJ and TORONTO, ON / ACCESSWIRE / December 17, 2018 / Eastgate Biotech Corp. (OTC PINK: ETBI), a pharmaceutical comp...Continue reading
09 Mar Uncategorized EastGate Biotech Appoints World Renown Diabetes Key Opinion Leader Dr Lalit Upadhyay for Upcoming Initiatives March 9, 2022 By admin 0 comments Key Opinion Leader spreading awareness of diabetes endorses the company’s liquid insulin mouth rinse solution for Type 2 diabetes and p...Continue reading
09 Mar Uncategorized CORRECTED LINK: CEO Anna Gluskin’s interview with Uptick Newswire on 17 October 2018 March 9, 2022 By admin 0 comments https://upticknewswire.com/interview-ceo-anna-gluskin-of-eastgate-biotech-corp-otcpink-etbi/Continue reading
09 Mar Uncategorized CEO Anna Gluskin, Interview with Uptick Network on October 17, 2018 March 9, 2022 By admin 0 comments https://upticknewswire.com/wp-content/uploads/2018/10/Uptick-Network-ETBI-Interview-10-17-18.mp3Continue reading
09 Mar Uncategorized CEO Anna Gluskin’s interview-Uptick network 17Oct2018 March 9, 2022 By admin 0 comments https://upticknewswire.com/wp-content/uploads/2018/10/Uptick-Network-ETBI-Interview-10-17-18.mp3Continue reading
09 Mar Uncategorized EastGate Biotech Signs Definitive Investment March 9, 2022 By admin 0 comments Non-Dilutive Investment and Product License includes licensing fee and development costs WEST CALDWELL, N.J. and TORONTO, August 27, 2...Continue reading
09 Mar Uncategorized EastGate Biotech Provides Update on investment from Genluiching Mining Corporation March 9, 2022 By admin 0 comments EastGate Biotech Provides Update on investment from Genluiching Mining Corporation. EastGate to receive the first non-dilut...Continue reading
09 Mar Uncategorized EastGate Biotech Expands Indications of Liquid Insulin Mouth Rinse Solution to Alzheimer’s Disease with Joint Venture Partner Genome Pharmaceuticals March 9, 2022 By admin 0 comments Genome Pharma is the parent company of Netris/Origin BioPharmaceuticals the company’s Joint Venture Partner WEST CALD...Continue reading
09 Mar Uncategorized EastGate Biotech Unveils Manufacturing Plans in an MOU with Mystic Pharmaceuticals Limited for its Liquid Insulin Mouth Rinse Solution March 9, 2022 By admin 0 comments WEST CALDWELL, NJ and TORONTO, June 21, 2018 (AccessNewswire-) EastGate Biotech Corp. (PinkSheets: ETBI), a pharmaceutical company that...Continue reading